Redha Bourouina
Antony
Profil professionnel
Medical doctor with 10+ years of experience in oncology and hematology within international pharmaceutical companies. Strong track record at the interface of medical strategy, data generation and scientific innovation. Experienced in complex environments, multi-indication launches and international matrix collaboration. Recognized for the ability to build a clear medical vision, engage cross-functional teams and turn field insights into concrete, measurable action plans.
Vue d'ensemble
25
25
years of professional experience
3
3
years of post-secondary education
Expérience
THERAPEUTIC AREA LEAD ONCOLOGY & HEMATOLOGY
IPSEN PHARMA
2023.01 - Current
- Lead the medical strategy for oncology and hematology in alignment with global strategy.
- Adapt and execute global medical plans at affiliate level (launches, data generation, medical education).
- Drive strong cross-functional collaboration (Market Access, Marketing, Regulatory, HEOR, Public Affairs).
- Maintain regular interactions with health authorities, scientific societies and patient organizations.
- Lead pre-launch and launch activities for key products, including:
- Tazemetostat (lymphomas, hematologic malignancies, solid tumors)
- Pipeline molecules in acute myeloid leukemia (AML)
- Cabozantinib in combination in lung and renal cancers
- Cabozantinib in neuroendocrine tumors
- Tovorafenib in pediatric low-grade glioma
- Monoclonal Antibody (ICT01) in acute myeloid leukemia
SENIOR MEDICAL ADVISOR ONCOLOGY & HEMATOLOGY
IPSEN PHARMA
2019.01 - 2023.01
- Implement and adapt global medical strategy at affiliate level.
- Map and engage centers of excellence, experts, scientific associations and patient organizations.
- Act as key internal and external scientific reference for the hemato-oncology portfolio.
- Oversee RWD projects (phase IV and phase II studies, databases, electronic medical records).
- Manage compassionate use and early access requests.
- Coordinate with the MSL team (workshops, insight management, critical review of scientific data). Organize and deliver training for MSLs.
- Supervise 2 medical advisors (initially under recruitment).
- Develop cross-affiliate workshops (insight sharing, critical review of new data, Cover major international congresses: select key communications, build slide decks, train affiliate champions.
- Collaborate with global clinical teams to ensure country participation in research studies (design, adaptation, follow-up).
- Support pre-launch of Cabozantinib in combination with immunotherapies in lung and renal cancers.
- Act as medical interface with Market Access: contribute to transparency and medico-economic dossiers, early access programs and responses to medical / scientific questions from health authorities.
- Develop patient support tools in collaboration with patient organizations.
- Train sales teams.
MEDICAL ADVISOR / MSL – HEMATO-ONCOLOGY
ASTELLAS PHARMA
2014.01 - 2019.01
- Lead pre-launch and launch activities for Gilteritinib (acute myeloid leukemia) and launch of Enzalutamide (prostate cancer).
- Build and strengthen advocacy for company products and research among KOLs, academic centers, professional societies, patient advocacy groups, hospital administration and payers.
- Prepare and deliver scientific and medical information; speak at scientific meetings; take part in advisory boards and face-to-face KOL meetings.
- Implement medical communication activities at local and international congresses.
- Provide scientific expertise to internal and external stakeholders and respond to medical information requests.
- Represent the company at key oncology and hematology meetings.
- Train MSLs and sales teams on products and therapeutic landscapes.
- Support the publication plan (manuscripts, abstracts, posters).
- Manage RWD activities and contribute to follow-up of international phase III and investigator-initiated studies.
- Support internal education through clinical data communication and knowledge transfer.
MEDICAL MANAGER – HEMATO-ONCOLOGY
MEDICAL COMMUNICATION AGENCY
2001.01 - 2004.01
- Conduct scientific intelligence and competitive analysis (review, synthesis and positioning of data).
- Contribute to strategic communication plans for oncology and hemato-oncology products.
- Cover international congresses (development of slide decks, expert interviews).
- Set up and coordinate advisory boards, workshops, standalone meetings and scientific exchange sessions.
- Maintain strong scientific interactions with KOLs and opinion leaders in hemato-oncology.
- Main clients: Roche, Gilead, AbbVie, Janssen, Pfizer, Celgene
Formation
D.E.S.S. - Computer Science & Applications to Life Sciences
René Descartes University
Paris 2000.01 - 2001.01
Radiology Fellowship -
Paris Hospitals
Paris 1998.01 - 2000.01
Medical Doctor (M.D.) -
University of Medical Sciences of Algiers
AlgiersCompétences
- Oncology & Hematology expertise
- Medical Affairs strategy
- Product (Pre-)launches
- Data generation
- Stakeholders engagement
- Management of medical teams
Language
French
Bilingual
C2
English
Advanced
C1
Personnalisé
- Cycling
- Medical and digital innovation in oncology
- Patient pathway and support initiatives in cancer care
Chronologie
THERAPEUTIC AREA LEAD ONCOLOGY & HEMATOLOGY
IPSEN PHARMA
2023.01 - Current
SENIOR MEDICAL ADVISOR ONCOLOGY & HEMATOLOGY
IPSEN PHARMA
2019.01 - 2023.01
MEDICAL ADVISOR / MSL – HEMATO-ONCOLOGY
ASTELLAS PHARMA
2014.01 - 2019.01
MEDICAL MANAGER – HEMATO-ONCOLOGY
MEDICAL COMMUNICATION AGENCY
2001.01 - 2004.01
D.E.S.S. - Computer Science & Applications to Life Sciences
René Descartes University
2000.01 - 2001.01
Radiology Fellowship -
Paris Hospitals
1998.01 - 2000.01
Medical Doctor (M.D.) -
University of Medical Sciences of Algiers